Curtis,
Here's what you said:
"thus the physician will have a new tool to help them decide if the cancer is still active and
hot or cooling and less active.
if i was a woman and i knew that mammogram had radiation and cti did not--and i had
breast cancer treatment--i would want some kind of marker like a cti scan to watch it
each month or so."
It's unfair and misleading to women with cancer and their physicians to suggest this as a role for CTI until the data is available - which won't be for years.
Even if you wish to change the focus to "suspicious lumps", I think you've got your concepts wrong, or I else do. Since when do women with suspicious lumps get treated with chemo and radiation? Either they have cancer, have it removed, and then get treated in hopes of preventing any recurrence, or they have a suspicious lump, which might need to be followed, but which is not (to my knowledge) treated with chemo or radiation. Therefore your premise, whatever kind of lesion you are talking about, that this chemo and radiation treatment success could be followed with CTI doesn't fit with anything I know about the treatment of the disease.
I will repeat - I do not think you are doing CTI, investors, or women with breast cancer a favor by making this kind of speculation. If you can direct us to an expert in the field (which I am not) who can verify these concepts, that would be of value, and I would certainly reconsider my statement (which I apologize for being so blunt, I just don't know how else to say it).
Bob |
